Eli Lilly & Company
 |
|
| Public | |
| Traded as |
|
| Industry | Pharmaceuticals |
| Founded | 1876 |
| Founder | Eli Lilly |
| Headquarters | Indianapolis, Indiana, U.S. |
|
Key people
|
David A. Ricks (Chairman of the Board, President, and CEO) |
| Products | Pharmaceutical drugs |
| Revenue |
 US$ 22.871 billion (2017)
|
 US$ 2.145 billion (2017)
|
|
|
US$ -204.1 million (2017)
|
|
| Total assets |
US$ 44.981 billion (2017)
|
| Total equity |
US$ 11.668 billion (2017)
|
|
Number of employees
|
40,655 (2017) |
| Website | Lilly.com |
David A. Ricks (Chairman of the Board, President, and CEO)
Eli Lilly and Company is a global pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War, after whom the company was named.
Lilly's notable achievements include being the first company to mass-produce the polio vaccine developed by Jonas Salk, and insulin. It was one of the first pharmaceutical companies to produce human insulin using recombinant DNA including Humulin (insulin medication), Humalog (Insulin lispro), and the first approved biosimilar insulin product in the US, Basaglar (insulin glargine).
Lilly is currently the largest manufacturer of psychiatric medications and produces Prozac (fluoxetine), Dolophine (methadone), Cymbalta (duloxetine), and Zyprexa (olanzapine).
The company is ranked 132nd on the Fortune 500. It is ranked 221st on the Forbes Global 2000 list of the largest public companies in the world and 252nd on the Forbes list of America's Best Employers.
...
Wikipedia